Background
Subchondral insufficiency fracture of the knee (SIFK) causes acute knee pain in adults and often requires surgical management. Unicompartmental knee arthroplasty (UKA) and total knee arthroplasty (TKA) are the two most common surgical treatments for SIFK. While both UKA and TKA have their advantages, there is no consensus for SIFK localized on the medial compartment. We hypothesized that patients with SIFK treated with UKA would show superior patient-reported outcomes compared to those who underwent TKA.
Methods
A total of 90 patients with SIFK were included in the TKA (n = 45) and UKA (n = 45) groups, respectively. SIFK lesions were measured on MR images. Hip knee ankle (HKA) angle was obtained preoperatively and at the final follow-up. Patient-reported outcomes in the form of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Hospital Special Surgery (HSS) scores, and Knee Society Scores (KSS) were assessed preoperatively, post-operative 6, 12 months, and at the final follow-up.
Results
The UKA group had better range of motion of the knee preoperatively and postoperatively than the TKA group (p<.01 and p<.01). At 6 months, WOMAC score was better in the UKA group than the TKA group (p<.01). Both groups had a significant improvement in WOMAC, HSS, and KSS scores at the final follow-up compared to preoperative scores. There were no surgical complications in the TKA group, but the UKA group had 3 revision cases due to a bearing failure.
Conclusion
Unicompartmental arthroplasty and total joint arthroplasty can produce successful outcomes in patients with SIFK with proper patient selection, regardless of the size of SIFK lesion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.